scholarly journals Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”

Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 505
Author(s):  
Jochen Neuhaus

The search for novel prostate cancer biomarkers is one of the major topics in recent urologic research [...]

Oncotarget ◽  
2015 ◽  
Vol 6 (30) ◽  
pp. 30357-30376 ◽  
Author(s):  
Anders Øverbye ◽  
Tore Skotland ◽  
Christian J. Koehler ◽  
Bernd Thiede ◽  
Therese Seierstad ◽  
...  

2010 ◽  
Vol 45 (1) ◽  
pp. 60-67 ◽  
Author(s):  
Lars Häggarth ◽  
Christina Hägglöf ◽  
Sara Jonmarker Jaraj ◽  
Kenneth Wester ◽  
Fredrik Pontén ◽  
...  

2013 ◽  
Vol 20 (1) ◽  
pp. 39-44 ◽  
Author(s):  
Sarah Hawley ◽  
Ladan Fazli ◽  
Jesse K. McKenney ◽  
Jeff Simko ◽  
Dean Troyer ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Alien Balian ◽  
Frank J. Hernandez

AbstractEarly cancer diagnosis is a crucial element to improved treatment options and survival. Great research efforts have been made in the search for better performing cancer diagnostic biomarkers. However, the quest continues as novel biomarkers with high accuracy for an early diagnosis remain an unmet clinical need. Nucleases, which are enzymes capable of cleaving nucleic acids, have been long considered as potential cancer biomarkers. The implications of nucleases are key for biological functions, their presence in different cellular counterparts and catalytic activity led the enthusiasm towards investigating the role of nucleases as promising cancer biomarkers. However, the most essential feature of these proteins, which is their enzymatic activity, has not been fully exploited. This review discusses nucleases interrogated as cancer biomarkers, providing a glimpse of their physiological roles. Moreover, it highlights the potential of harnessing the enzymatic activity of cancer-associated nucleases as a novel diagnostic biomarker using nucleic acid probes as substrates.


Sign in / Sign up

Export Citation Format

Share Document